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influences the pharmacokinetics of the drugs adversely. 
This preliminary report of an ongoing study confirms 
the long-held suspicion that reinfection does occur in 
a TB hospital setting in a developing country. What 
is surprising, however, is the transmission of fully 
susceptible strains to patients who are still on therapy. 
It is, therefore, tempting to hypothesize that prolonged 
hospitalization aimed at improving compliance will 
provide the environment for the acquisition of different 
strains by patients on treatment, thereby prolonging the 
time it takes to effect cure. The recently completed TB 
Review by a panel of international experts indicates a 
cure rate of 30-60% in South Africa [4]. The WHO 
has suggested that when cure rates fall below 50%, 
there can be a negative epidemiologic impact on the 
prevalence of smear-positive cases, especially in the 
presence of improved case finding. This is a result of 
increased numbers of chronic transmitters emanating 
fiom therapeutic failures [ 5 ] .  It is hoped that ongoing 
studies in this laboratory will serve to firmly document 
this phenomenon with a view to influencing admission 
policy in hospital settings. 
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Catheter-related bacteremia due to Tsukamurella pulmonis 
Clin Microbiol Infect 1998; 4: 51-53 
Catheter-related bacteremia is an important problem 
for patients with hematologic malignancies in whom 
long-term venous access is required for the safe 
administration of high-dose chemotherapy and optimal 
supportive care. These infections are mainly caused 
by organisms colonizing the skin. Coagulase-negative 
staphylococci and Staphylococcus aureus are the leading 
causes of catheter-related infection. Other reported 
pathogens include Stenotrophomonas maltophilia, Burk- 
holderia cepacia, Corynebacterium sp. and Candida spp. 
Here we report the first case of bacteremia caused by 
Tsukamurella pulmonis; a Hickman catheter-related 
bacteremia in a patient with malignant lymphoma. 
A 38-year-old woman had been well until January 
1995, when she presented with a subacute superior 
vena cava syndrome due to the mediastinal involvement 
of an extended-stage high-grade mahgnant B-cell non- 
Hodgkin’s lymphoma (Burkitt-like). After a brief 
period of radiotherapy and steroids, a Hickman catheter 
was implanted for the administration of several cycles 
of intensive cytoreductive therapy. Remission-induction 
therapy, consisting of daunorubicin, vincristine, cyclo- 
phosphamide, steroids and intrathecal prophylaxis, 
resulted in complete remission. Therapy was completed 
by two consolidation courses and radiotherapy. 
In October 1995 she was readmitted to the hospital 
for autologous peripheral blood progenitor cell trans- 
plantation. Four days before the transplantation, the 
patient developed spiking fever, diarrhea and cramping 
abdominal pain with nausea and vomiting. Because of 
her neutropenic status (l100/mm3), she was started on 
intravenous ceftazidime for a total of 7 days. Repeated 
cultures from blood and stool samples yielded no 
pathogens; chest and abdominal X-ray and ultrasound 
examination were unremarkable. Within the next 2 
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days, the patient's fever subsided while the neutrophil 
count fully recovered, so the transplantation procedure 
was started as planned. The patient was nursed in a 
reverse isolation room with high-efficiency particulate 
air (HEPA) filtration. Selective gut decontamination 
with ofloxacin and itraconazole was performed as well 
as antistreptococcal and anti-viral prophylaxis with 
penicillin G and acyclovir respectively. The patient 
received a standard myeloablative conditioning regimen 
followed by the reinfusion of cryopreserved autologous 
peripheral blood progenitor cells. O n  the first day after 
transplantation, the patient developed a temperature 
of 38.6OC without rigors. Physical examination was 
completely negative and vital parameters were within 
normal limits. Therapy with ceftazidime and teico- 
planin was started because of severe neutropenia. 
During the next few days, the patient remained 
only mildly febrile, with maximal temperatures of 
38.1 O C .  Daily blood cultures remained sterile. How- 
ever, on day 7 after the transplantation, the patient 
experienced another bout of fever up to 38.4OC. A few 
crackles were heard at both lung bases. Inspection of 
the catheter exit site revealed no signs of infection. 
Except for grade IV mucositis, no other physical 
abnormalities were found. Relevant laboratory findings 
included 0 leukocytes/mm3, platelets 16.000/mm3, 
hemoglobin 7.7 g/dL, and normal renal and hepatic 
function. Blood cultures drawn through the Hickman 
line and by peripheral venipuncture yielded Gram- 
positive rods, initially identified as Covynebacteriurn 
species. Therapy was changed from teicoplanin to 
vancomycin. However, the patient remained mildly 
febrile until neutrophil recovery. O n  day + 14, she was 
afebrile and discharged from the hospital with an 
absolute neutrophil count of 8100/mm3. 
Three days later, she was readmitted because of 
shaking chills and a temperature of 39.5"C. Again, 
physical examination revealed no obvious source of 
infection. Remarkable laboratory findings included 
3100 leukocytes/mm3, hemoglobin 9.5 g/dL, and C 
reactive protein of 13.6 mg%. At that time, the patient 
was still receiving ofloxacin. Teicoplanin was initiated 
through every lumen of the Hickman catheter. Blood 
cultures drawn through the three parts of the Hickman 
line and peripherally yielded the same Gram-positive 
rods. During the following days, the patient remained 
intermittently febrile and several blood cultures were 
positive. Hence, the catheter was withdrawn, and 
culture of the tip yielded the same coryneform. For ty  
eight hours after catheter withdrawal, the patient 
defervesced and subsequent blood cultures were 
negative. Therapy with teicoplanin was continued for 
another 8 days. Currently, the patient is without any 
evidence of infection 14 months later. 
A total of 14 blood culture sets (High Volume 
Kesine, Bactec plus 26 (aerobic) and 27 (anaerobic), 
Becton Dickinson) from this patient were examined. 
Out of these 14 blood culture sets, six aerobic vials, 
taken on three different days, revealed the presence of 
straight or slightly curved bacilli resembling 'diph- 
theroids'. The mean time between drawing of the 
blood and positivity of the blood cultures was 1 day. 
The organism grew aerobically within 24 h on 
trypticase soy agar with 5% horse blood, producing dry, 
rough, yellow-pigmented colonies without evidence of 
hemolysis or pitting of the medium. The organism was 
catalase and urease positive, while oxidase and nitrate 
reductase were negative. It did not hydrolyze casein, 
xanthine or tyrosine and did not grow at 45°C. It  
utilized numerous carbon sources such as dextrose, 
mannitol, sucrose, sorbitol and trehalose, but not 
lactose, maltose and inositol. The presence of mycolic 
acids was detected by thin-layer chromatography after 
acid methanolysis [l]. Results were compared to 
those obtained in Tsukamure/la reference strains: 7: 
paurornetabola ATCC 8368T, 7: inchonensis DSM 
44067', and 7: pnlrnonir DSM 4414ZT. The spot 
representing u and u' mycolates was similar to that 
of the reference strain and was located at  the same 
migration distance. 
The 16s rDNA gene of the isolate was also 
amplified by polymerase chain reaction (PCR), cloned 
in a plasmid vector and sequenced on both strands. The 
nucleotide sequence turned out to be 99.9% similar 
(1472 positive matches out of 1473 residues) to the 16s 
rDNA sequence of 7: pulmonir strain DSM 44142T 
published by Yassin et a1 [2]. The access number to 
the GenBank database is AF002011. By the disk 
diffusion technique with NeoSensitabs (A/S Rosco, 
2630 Toastrup, Denmark) on Mueller-Hinton agar 
(Difco), the strain was susceptible to co-trimoxazole, 
doxycycline, ciprofloxacin, gentamicin, amikacin, 
vancomycin and imipeneni, but resistant to penicillin, 
ampicillin, erythromycin and third-generation cephalo- 
sporins. The genus ~sukarnnrel/n was proposed in 1988 
[3] for a group of aerobic actinotnycetes found 
primarily in soil and related to Rhodococcur and h'ocardin. 
At least three different species belong to the genus: 7: 
paurometabola, 7: irichonctzsis and 7: pulmoriis. Only a few 
cases of human infection due to Tsukaniureh sp. have 
been reported, particularly in patients with underlying 
chronic diseases and intravascular devices. The first 
infection due to T pauror?ietabola was described in a 50- 
year-old man with a chronic pulmonary infection [4]. 
A case of a necrotizing tenosynovitis of the forearm [ S ] ,  
a case of fatal meningitis [6], a case of peritonitis in 
a patient undergoing peritoneal dialysis [7] and several 
cases of bacteremia in patients with cancer 181 or 
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following hemodialysis [9] have also been described. 
Recently, Auerbach et a1 reported an outbreak of 
pseudoinfection with 7: paurometabola, due to culture 
contamination in the laboratory [lo]. T inchonensis was 
isolated from blood cultures of a patient who had 
ingested hydrochloric acid [I I]. To our knowledge, we 
give here the first report that clearly demonstrates the 
pathogenicity of T pulmonis. Interesting in these latter 
cases of bacteremia, and similar to our case report, is 
the absence of tunnel or exit-site inflammation and the 
persistence of fever and positive blood culture despite 
adequate antibiotic therapy until the catheter was 
removed. Moreover, catheter tip cultures implicated 
the catheter as source of infection in all cases, while 
catheter removal resulted in rapid clinical recovery and 
sterilization of blood cultures. Hence, Tsukarnurella sp. 
bacteremia might be, despite its Gram-positive nature, 
an indication for early catheter removal. 
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Prevalence of stably derepressed class I P-lactamase in 
multiresistant clinical isolates of Enrerobacrer cloacae in 
two Hungarian hospitals 
Clin Microbiol Infect 1998; 4: 53-55 
The clinical use of the new extended-spectrum 
cephalosporins was rapidly followed by the emergence 
of resistance to these antibiotics in several species, 
including Enterobacter cloacae. Therapeutic failures 
associated with the in vivo selection of stably 
derepressed mutants with permanent hyperproduction 
of the chromosomally encoded class I p-lactamases have 
been described for these strains [1,2]. Resistance to new 
extended-spectrum cephalosporins and other clinically 
important antibiotics in isolates of E. cloacae is 
increasing throughout the world. Resistance to 
cefotaxime, ceftazidime and ceftriaxone has been found 
in 68% of the strains in Greece [3]. However, the 
prevalence of resistance may vary among different 
geographical locations. It has been reported that 
resistance to extended-spectrum cephalosporins in 
E. cloacae is most prevalent in the southern part of 
Europe and Belgium [4], while only 5% of 233 isolates 
from a community hospital in the USA proved to be 
resistant to third-generation cephalosporins [5]. In 
addition to p-lactam resistance, a high number ofstrains 
have been observed with resistance to aminoglycosides 
as well [3]. 
We have evaluated the prevalence of resistance of 
p-lactams, aminoglycosides and quinolones in 82 
E. cloacae strains isolated from patients with severe 
infections in two hospitals in Hungary from January to 
August 1995. The origin ofthese strains was urine (32), 
wound samples (27), tracheal aspirates (lo), blood 
